SUMMARY Antigen from purified Mycoplasma pneumoniae organisms treated with Tween-80-ether was used in a solid phase enzyme immunoassay and compared with the conventional lipid containing complement fixation antigen for measuring antibodies in sera from patients with aseptic or bacterial meningitis or with apparent M pneumoniae infection. In immunoblotting of the enzyme immunoassay antigen, enzyme immunoassay positive sera detected a polypeptide at Mr = 180-00}-200-000, while enzyme immunoassay negative sera whether positive or negative in the complement fixation test did not. These results indicate that the enzyme immunoassay antigen containing the high molecular weight polypeptide can be used to measure M pneumoniae antibodies more specifically than the conventional lipid containing complement fixation antigen.
Considerable increases in the titres of complement fixing antibodies reactive with the glycolipid containing fraction of Mycoplasma pneumoniae have been reported in many kinds of infections and illnesses with or without other evidence of M pneumoniae infection.'-3 Examples of such illnesses are the infections and disorders of the central nervous system.4-" Some of these antibody responses may be due to cross reacting antibodies stimulated by vanous conditions.'2 Such antibodies often develop during acute pancreatitis. '3 14 On the other hand, antibodies against brain, lung, and liver tissue develop during M pneumoniae infections's and injections of mycoplasmas other than M pneumoniae can cause central nervous system symptoms in animals. '"-8 Our previous studies with enzyme immunoassay and a Tween-80-ether treated M pneumoniae antigen,'4 instead of the conventional lipid containing complement fixation antigen, supported, in conjunction with clinical evidence, the view that some of the rises in complement fixation antibody titres may be due to false positive reactions against the glycolipid moieties of the antigen. It seemed possible that a more purified M pneumoniae protein antigen could eliminate these reactions and make the serological diagnosis of M pneumoniae infection more reliable.
To clarify the possible role of M pneumoniae in central nervous system infections, we examined Values for the acute (1) and convalescent phase (2) (Fig. 3) . No such band could be found in the complement fixation antigen with sera positive both in the enzyme immunoassay and the complement fixation test. Also, enzyme immunoassay negative sera, whether negative or positive in the complement fixation test, failed to detect this band in either type of antigen.
The acute phase patient sera which had a low response in the M pneumoniae enzyme immunoassay test often failed to show the Mr = 180-00-200-000 antigen or gave a faint reaction; convalescent phase sera were able to detect the zone clearly. toms had significant concentrations of antibodies in enzyme immunoassay as well. Both patients had respiratory infections associated with neurological symptoms: one hed&an acute respiratory infection, negative cold agglutinin titres, and a lower-IgG concentration against the enzyme immunoassay antigen in the convalescent phase serum than in the acute phase sample; the other had a rise in antibody concentration in the enzyme immunoassay and an increase in the cold agglutinin titres and developed pneumonia after the central nervous system symptoms ( Figs. 1 and 2 ). Sera from all the patients with a typical pneumonia and positive complement fixation titres were clearly positive in the M pneumoniae enzyme immunoassay test as well (Figs.  1 and 2 ). These patients also had raised cold agglutinin titres in their convalescent phase sera. Sera from healthy one year old children and from patients with pneumonia with no increase in complement fixation antibody titre did not respond in the enzyme immunoassay test to the Tween 80-ether treated M pneumoniae antigen. the mycoplasma surface protein P1 concerned in the attachment of the organisms to respiratory epithelium described by Hu et al.2425 We did not detect this polypeptide when either complement fixation positive/enzyme immunoassay negative or complement fixation negative/enzyme immunoassay negative sera were used. These results also agree well with those made with whole M pneumoniae Raisanen, Suni, Vaheri organisms and monoclonal antibodies.262" In these studies the main antigenic entity of the M pneumoniae organism is a high molecular weight protein.
The enzyme immunoassay antigen containing this antigenic polypeptide appears to be reliable in the diagnosis of M pneumoniae infection.
